JAZZ — Jazz Pharmaceuticals PLC · P/E 1988, rev $2.28B

Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.

Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.

Use this JAZZ page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the JAZZ quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the JAZZ SEC filings page. Lician reads the product cache first so this HTML stays unique to Jazz Pharmaceuticals PLC even when a live quote feed is slow.